Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2020

May 15, 2020

SELL
$34.37 - $60.07 $1.38 Million - $2.41 Million
-40,200 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$54.32 - $64.31 $1.93 Million - $2.29 Million
35,600 Added 773.91%
40,200 $2.42 Million
Q3 2019

Nov 14, 2019

SELL
$53.25 - $59.98 $351,450 - $395,868
-6,600 Reduced 58.93%
4,600 $260,000
Q2 2019

Aug 14, 2019

SELL
$46.61 - $58.45 $610,591 - $765,695
-13,100 Reduced 53.91%
11,200 $624,000
Q1 2019

May 15, 2019

BUY
$38.66 - $51.82 $479,383 - $642,568
12,400 Added 104.2%
24,300 $1.23 Million
Q4 2018

Feb 14, 2019

BUY
$36.72 - $67.73 $319,464 - $589,251
8,700 Added 271.88%
11,900 $479,000
Q3 2018

Nov 14, 2018

SELL
$66.65 - $83.86 $266,600 - $335,440
-4,000 Reduced 55.56%
3,200 $222,000
Q2 2018

Aug 14, 2018

SELL
$51.25 - $76.62 $1.06 Million - $1.58 Million
-20,600 Reduced 74.1%
7,200 $545,000
Q1 2018

May 15, 2018

BUY
$52.16 - $66.86 $1.3 Million - $1.67 Million
25,000 Added 892.86%
27,800 $1.47 Million
Q4 2017

Feb 14, 2018

SELL
$49.6 - $60.87 $163,680 - $200,871
-3,300 Reduced 54.1%
2,800 $148,000
Q3 2017

Nov 14, 2017

BUY
$46.62 - $60.36 $149,184 - $193,152
3,200 Added 110.34%
6,100 $364,000
Q2 2017

Aug 14, 2017

BUY
N/A
2,900
2,900 $229,000

Others Institutions Holding EGRX

About EAGLE PHARMACEUTICALS, INC.


  • Ticker EGRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 13,015,900
  • Market Cap $13M
  • Description
  • Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...
More about EGRX
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.